10 citations · 77 across the 24 of their papers we have counts for
4 papers · 1 filter
HIV, TB and ART: the CD4 enigma
Brian Williams, Eleanor Gouws
The concentration of CD4 T-lymphocytes (CD4 count), in a person's plasma is widely used to decide when to start HIV-positive people on anti-retroviral therapy (ART) and to predict…
Pre-exposure prophylaxis (PrEP) versus treatment-as-prevention (TasP) for the control of HIV: Where does the balance lie?
Brian G. Williams, Eleanor Gouws, John Hargrove +2
Anti-retroviral drugs can reduce the infectiousness of people living with HIV by about 96%--treatment as prevention or TasP--and can reduce the risk of being infected by an HIV pos…
Anti-retroviral therapy for HIV: who should we test and who should we treat?
Brian G. Williams, Renier van Rooyen, Martin Nieuwoudt
In most countries CD4+ cell counts are still used for deciding when to start HIV-positive people on anti-retroviral therapy. However, various CD4+ thresholds, 200, 350 or 500/\muL,…
Affordability, cost and cost-effectiveness of universal anti-retroviral therapy for HIV
Brian G. Williams, Eleanor Gouws
If people at risk of HIV infection are tested annually and started on treatment as soon as they are found to be HIV-positive it should be possible to reduce the case reproduction n…